Circulating cell-free DNA in plasma of melanoma patients: Qualitative and quantitative considerations

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2141-2145

  Pinzani, Pamela ^a   Salvianti, Francesca ^a   Zaccara, Sara ^a   Massi, Daniela ^a   De Giorgi, Vincenzo ^a   Pazzagli, Mario ^a   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cell free DNA; DNA integrity index; Melanoma; QPCR

Indexed keywords

DNA; GENOMIC DNA;

ADULT; AGED; AMPLICON; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL FREE DNA FRAGMENTATION; CONTROLLED STUDY; DNA DETERMINATION; DNA FRAGMENTATION; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

BASE SEQUENCE; DNA PRIMERS; DNA, NEOPLASM; HUMANS; MELANOMA; POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 80053642375     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.07.027     Document Type: Article

References (21)

1. van der Vaart M., Pretorius P.J. Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci 2008, 1137:18-26.
2. Fleischhacker M., Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007, 1775:181-232.
3. Jung K., Fleischhacker M., Rabien A. Cell-free DNA in the blood as a solid tumor biomarker - a critical appraisal of the literature. Clin Chim Acta 2010, 411:1611-1624.
4. Chen Z., Fadiel A., Naftolin F., Eichenbaum K.D., Xia Y. Circulation DNA biological implications for cancer metastasis and immunology. Med Hypotheses 2005, 65:956-961.
5. Umetani N., Giuliano A.E., Hiramatsu S.H., et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006, 24:4270-4276.
6. Wang B.G., Huang H.Y., Chen Y.C., et al. Increased plasma DNA integrity in cancer patients. Cancer Res 2003, 63:3966-3968.
7. Jiang W.W., Zahurak M., Goldenberg D., et al. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer 2006, 119:2673-2676.
8. Hanley R., Rieger-Christ K.M., Canes D., et al. DNA integrity assay a plasma-based screening tool for the detection of prostate cancer. Clin Cancer Res 2006, 12:4569-4574.
9. Gang F., Guorong L., An Z., Anne G.P., Christian G., Jacques T. Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum. Urology 2010, 75:262-265.
10. Hauser S., Zahalka T., Ellinger J., et al. Cell-free circulating DNA Diagnostic value in patients with renal cell cancer. Anticancer Res 2010, 30:2785-2789.
11. Tomita H., Ichikawa D., Ikoma D., et al. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer. Anticancer Res 2007, 27:2737-2741.
12. Chan K.C., Leung S.F., Yeung S.W., Chan A.T., Lo Y.M. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients. Clin Cancer Res 2008, 14:4141-4145.
13. Umetani N., Kim J., Hiramatsu S., et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer direct quantitative PCR for ALU repeats. Clin Chem 2006, 52:1062-1069.
14. Ellinger J., Bastian P.J., Ellinger N., et al. Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer a prognostic entity. Cancer Lett 2008, 264:274-280.
15. Ellinger J., Bastian P.J., Haan K.I., et al. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. Int J Cancer 2008, 122:138-143.
16. Ellinger J., Wittkamp V., Albers P., et al. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 2009, 181:363-371.
17. Schmidt B., Weickmann S., Witt C., Fleischhacker M. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann N Y Acad Sci 2008, 1137:207-213.
18. Holdenrieder S., Burges A., Reich O., Spelsberg F.W., Stieber P. DNA integrity in plasma and serum of patients with malignant and benign diseases. Ann N Y Acad Sci 2008, 1137:162-170.
19. Lehmann U., Glöckner S., Kleeberger W., von Wasielewski H.F., Kreipe H. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 2000, 156:1855-1864.
20. Jahr S., Hentze H., Englisch S., et al. DNA fragments in the blood plasma of cancer patients quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665.
21. Suzuki N., Kamataki A., Yamaki J., Homma Y. Characterization of circulating DNA in healthy human plasma. Clin Chim Acta 2008, 387:55-58.